TrialCancer prevention research (Philadelphia, Pa.)2022

Cancer Prevention with Resistant Starch in Lynch Syndrome Patients in the CAPP2-Randomized Placebo Controlled Trial: Planned 10-Year Follow-up.

John C Mathers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.